Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

AI Briefing

• – Senti Biosciences reports Q4 and FY 2025 financial results, provides corporate update.
• – Company's pipeline and corporate highlights include recent developments in Gene Circuit platform.
• – Financial results to be discussed in a conference call on March 31, 2026.